Related Experiment Videos
[Therapeutic principles in gastroesophageal reflux]
O Chassany1, D Elkharrat, J F Bergmann
1Service médical d'accueil, hôpital Lariboisière, Paris, France.
La Revue De Medecine Interne
|January 1, 1995
Summary
Gastroesophageal reflux disease (GERD) management focuses on symptom relief, healing esophageal damage, and preventing relapses. Effective drug therapies exist, but optimal long-term strategies require further study.
Area of Science:
- Gastroenterology
- Pharmacology
Context:
- Gastroesophageal reflux is a prevalent condition.
- Chronic GERD can lead to erosive esophagitis.
- Current drug therapies target gastric acidity and motility.
Purpose:
- To outline the aims of GERD treatment: symptom improvement, healing lesions, and preventing relapses.
- To review current therapeutic approaches for symptomatic reflux and esophagitis.
- To identify areas for future research in long-term GERD management.
Summary:
- Non-drug measures are supportive, though their efficacy is not fully established.
- Initial treatments like antacids, prokinetics, and H2 receptor antagonists are often effective for mild cases.
- Proton-pump inhibitors are key for healing and preventing severe esophagitis.
Impact:
- Long-term safety concerns with potent acid inhibitors, like hypergastrinemia, appear resolved.
- Further research is needed to determine optimal low-dose maintenance therapies for preventing GERD relapses.